Alexandria Co. For Pharmaceuticals & Chemical Industries Stock
Stocks
AXPH
EGS38341C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
09/11/2026
|
5-day change | 1st Jan Change | ||
| 1,356.39 EGP | +2.01% |
|
+3.14% | +69.47% |
| Market Cap | 6.78B 126M 112M 103M 93.82M 178M 11.8B 182M 1.24B 493M 6.32B 472M 462M 19.89B | P/E 2025 |
5.7x | P/E 2026 | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 6.39B 119M 106M 97.47M 88.46M 168M 11.12B 172M 1.17B 465M 5.96B 445M 436M 18.76B | EV / Sales 2025 |
0.71x | EV / Sales 2026 | 1.64x |
| Free-Float |
17.74% | Yield 2025 |
14.1% | Yield 2026 | 5.63% |
| 1 day | +2.01% | ||
| 1 week | +3.14% | ||
| Current month | -2.55% | ||
| 1 month | -9.31% | ||
| 3 months | +5.67% | ||
| 6 months | +38.47% | ||
| Current year | +69.47% |
| 1 week | 1,313 |  | 1,369.9 |
| 1 month | 1,135 | | 1,520 |
| Current year | 701.66 | | 1,987 |
| 1 year | 701.66 | | 1,987 |
| 3 years | 145.05 | | 1,987 |
| 5 years | 85 | | 1,987 |
| 10 years | 50 | | 1,987 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | +3.14% | +67.65% | +739.61% | 126M | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,258B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 679B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 518B | |
| -0.54% | +2.15% | +43.21% | +68.70% | 390B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 367B | |
| +0.30% | +1.99% | +31.23% | +59.93% | 307B | |
| -0.60% | +1.76% | +6.68% | +38.77% | 293B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 252B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 210B | |
| Average | +0.58% | +1.25% | +44.67% | +149.69% | 427B | |
| Weighted average by Cap. | +0.45% | +1.18% | +45.38% | +96.82% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.75B 51.05M 45.56M 41.93M 38.05M 72.11M 4.78B 73.9M 502M 200M 2.56B 192M 187M 8.07B | 3.18B 59.06M 52.72M 48.51M 44.03M 83.44M 5.54B 85.51M 580M 231M 2.96B 222M 217M 9.33B |
| Net income | 391M 7.26M 6.48M 5.96M 5.41M 10.26M 680M 10.51M 71.33M 28.43M 364M 27.25M 26.66M 1.15B | 525M 9.74M 8.69M 8M 7.26M 13.76M 913M 14.1M 95.69M 38.14M 489M 36.56M 35.77M 1.54B |
| Net Debt | -282M -5.23M -4.67M -4.29M -3.9M -7.39M -490M -7.57M -51.37M -20.47M -262M -19.62M -19.2M -826M | -387M -7.19M -6.42M -5.91M -5.36M -10.16M -674M -10.41M -70.64M -28.16M -361M -26.98M -26.41M -1.14B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | EGP 1,356.39 | +2.01% | 4,773 |
| 08/11/26 | EGP 1,329.70 | -0.44% | 2,447 |
| 05/11/26 | EGP 1,335.59 | +1.24% | 2,883 |
| 04/11/26 | EGP 1,319.29 | +0.25% | 4,022 |
| 03/11/26 | EGP 1,315.98 | +0.07% | 2,949 |
- Stock Market
- Stocks
- AXPH Stock
Select your edition
All financial news and data tailored to specific country editions
